{"id":"W4247199942","doi":"10.1002/14651858.cd007572.pub2","title":"Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease","year":2015,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"","field":"","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Ustekinumab; Internal medicine; Adverse effect; Placebo; Crohn's disease; Randomized controlled trial; Relative risk; Clinical trial; Meta-analysis; Number needed to treat; Confidence interval; Disease; Adalimumab; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01065639,0.001199445,0.008298965,0.008010834,0.0003609328,0.002188603,0.001644961,0.002772327,0.005424164],"category_scores_gemma":[0.03107122,0.0006343122,0.006848998,0.005661975,0.0007810646,0.001731307,0.0008051865,0.001541888,0.0004038456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002321289,"about_ca_system_score_gemma":0.003566087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001692299,"about_ca_topic_score_gemma":0.003046001,"domain_scores_codex":[0.9895873,0.004532925,0.003475468,0.0005478464,0.001698142,0.0001583215],"domain_scores_gemma":[0.9719735,0.02075763,0.005734682,0.0002237993,0.001093785,0.0002165939],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001364901,0.00004304234,0.0004049302,0.9076048,0.007473364,0.0001079636,0.00008834764,0.0001398355,0.0003149582,0.000426283,0.001392543,0.08063908],"study_design_scores_gemma":[0.00518857,0.001657199,0.005579414,0.8502827,0.09323157,0.00094694,0.0002540679,0.0003024604,0.0009372042,0.001108183,0.04044601,0.00006558723],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005724068,0.9987453,0.00007166492,0.0001251581,0.00009103396,0.00015194,0.00004718399,0.000004123525,0.0001911128],"genre_scores_gemma":[0.01447745,0.9827886,0.0009489195,0.0005580102,0.0002044369,0.0007417578,0.0000889735,0.000005069946,0.0001868499],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01065639,"threshold_uncertainty_score":0.05635703,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2252052810210839,"score_gpt":0.4320186707715892,"score_spread":0.2068133897505054,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}